Skip to main content
. 2020 Oct 21;21(20):7792. doi: 10.3390/ijms21207792
POI Primary ovarian insufficiency
ASCO American Society of Clinical Oncology
HFEA Human Fertilization and Embryology Authority
ASRM American Society for Reproductive Medicine
CMF Cyclophosphamide, methotrexate, fluorouracil
CEF Cyclophosphamide, epirubicin, fluorouracil
CAF Cyclophosphamide, doxorubicin (Adriamycin), fluorouracil
AC Doxorubicin (Adriamycin), cyclophosphamide
ABVD doxorubicin/bleomycin/vinblastin/dacarbazine
CHOP cyclophosphamide/doxorubicin/vincristine/prednisone
CVP cyclophosphamide/vincristine/prednisone
AML Acute myeloid leukemia
ALL Acute lymphoblastic leukemia
DSB Double-strand break
PI3K/AKT/FOXO3a Phosphoinositide 3-kinase/protein kinase B/forkhead box protein O3a
GnRH Gonadotropin-releasing hormone
OSC Ovarian stem cell
IVF In vitro fertilization
UK United Kingdom
NICE National Institute for Health and Care Excellence
IVM In vitro maturation
PCOS Polycystic ovarian syndrome
ART Assisted reproductive technology